Eli Lilly, Pfizer, Merck among Big Pharma losers in China's latest round of procurement bidding
The Pharma Data
AUGUST 20, 2020
On Thursday, domestic and global companies bid for contracts on 56 medicines. . DEVELOP A UNIFIED SCIENTIFIC VOICE. It has since expanded nationwide, threatening an important market for many Big Pharma players. . Virtual Event. It’s not a completely unforeseen shift, though. Source link.
52 
Let's personalize your content